care pathway

Patients

Today’s DTP platforms vary widely in standards, screening protocols, clinical follow-up, data use, and integration with a patient’s broader care team

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.